SC 13G

Company

Lyra Therapeutics, Inc.

Filed

December 30, 2020

Accession Number

0001193125-20-329939

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →